BRPI0711889B8 - método para produção de sinvastatina, composição de matéria, método para fabricação de huvastatina, método para fabricação de sinvastatina, e método para fabricação de uma composição de matéria de sinvastatina ou huvastatina - Google Patents
método para produção de sinvastatina, composição de matéria, método para fabricação de huvastatina, método para fabricação de sinvastatina, e método para fabricação de uma composição de matéria de sinvastatina ou huvastatinaInfo
- Publication number
- BRPI0711889B8 BRPI0711889B8 BRPI0711889A BRPI0711889A BRPI0711889B8 BR PI0711889 B8 BRPI0711889 B8 BR PI0711889B8 BR PI0711889 A BRPI0711889 A BR PI0711889A BR PI0711889 A BRPI0711889 A BR PI0711889A BR PI0711889 B8 BRPI0711889 B8 BR PI0711889B8
- Authority
- BR
- Brazil
- Prior art keywords
- making
- simvastatin
- huvastatin
- matter
- composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/42—Hydroxy-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
Abstract
método para produção de sinvastatina, composição de matéria, método para fabricação de huvastatina, método para fabricação de sinvastatina, e método para fabricação de uma composição de matéria de sinvastatina ou huvastatina a invenção aqui divulgada refere-se a métodos e materiais para produção de sinvastatina e compostos associados tal como huvastatina.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80808806P | 2006-05-24 | 2006-05-24 | |
US60/808.088 | 2006-05-24 | ||
PCT/US2007/012362 WO2007139871A2 (en) | 2006-05-24 | 2007-05-24 | Methods and materials for making simvastatin and related compounds |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0711889A2 BRPI0711889A2 (pt) | 2012-01-10 |
BRPI0711889B1 BRPI0711889B1 (pt) | 2019-12-24 |
BRPI0711889B8 true BRPI0711889B8 (pt) | 2021-05-25 |
Family
ID=38779209
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0711889A BRPI0711889B8 (pt) | 2006-05-24 | 2007-05-24 | método para produção de sinvastatina, composição de matéria, método para fabricação de huvastatina, método para fabricação de sinvastatina, e método para fabricação de uma composição de matéria de sinvastatina ou huvastatina |
Country Status (11)
Country | Link |
---|---|
US (4) | US8211664B2 (pt) |
EP (1) | EP2032715B1 (pt) |
KR (1) | KR101455794B1 (pt) |
CN (1) | CN101490271B (pt) |
AT (1) | ATE543910T1 (pt) |
BR (1) | BRPI0711889B8 (pt) |
CA (1) | CA2652883C (pt) |
IL (1) | IL195341A (pt) |
MX (1) | MX2008014778A (pt) |
RU (1) | RU2447152C2 (pt) |
WO (1) | WO2007139871A2 (pt) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2032715B1 (en) | 2006-05-24 | 2012-02-01 | The Regents of the University of California | Methods and materials for making simvastatin and related compounds |
WO2009056539A1 (en) * | 2007-10-30 | 2009-05-07 | Dsm Ip Assets B.V. | Fermentative production of simvastatin |
KR100959001B1 (ko) | 2007-12-27 | 2010-05-20 | 선웨이 바이오테크 코., 엘티디. | 알츠하이머병을 예방 및 치료하기 위한 조성물 및 그제조방법 |
ES2343049B1 (es) | 2008-10-15 | 2011-06-10 | Neuron Biopharma, S.A. | Biosintesis de derivados de monacolina j. |
HUE046680T2 (hu) | 2009-09-30 | 2020-03-30 | Codexis Inc | Javított Lov-D aciltranszferáz mediált acilezés |
EP2486129B1 (en) * | 2009-10-08 | 2016-04-13 | The Regents of The University of California | LovD MUTANTS EXHIBITING IMPROVED PROPERTIES TOWARDS SIMVASTATIN SYNTHESIS |
US9499803B2 (en) | 2009-10-08 | 2016-11-22 | The Regents Of The University Of California | Variant LovD polypeptide |
CN102043030A (zh) * | 2009-10-22 | 2011-05-04 | 北京万全阳光医学技术有限公司 | 一种用高效液相色谱法测定烟酸辛伐他汀缓释片有关物质的方法 |
CN102010831B (zh) * | 2010-05-26 | 2012-04-18 | 云南农业大学 | 一种产洛伐他汀紫色红曲菌霉mpt13 |
PL222067B1 (pl) * | 2011-08-11 | 2016-06-30 | Inst Biotechnologii I Antybiotyków | Kaseta ekspresyjna, zastosowanie kasety ekspresyjnej, wektor ekspresyjny, komórka prokariotycznego gospodarza zawierająca wektor ekspresyjny, szczep bakteryjny oraz sposób wytwarzania polipeptydu |
EP2730655A1 (de) | 2012-11-12 | 2014-05-14 | Evonik Industries AG | Verfahren zur Umsetzung eines Carbonsäureesters unter Verwendung BioH-defizienter Zellen |
CN104342417A (zh) * | 2013-08-09 | 2015-02-11 | 南京朗恩生物科技有限公司 | 源于土曲霉的活性增强的酰基转移酶突变体 |
CN103772248B (zh) * | 2014-01-06 | 2016-06-08 | 苏州汉酶生物技术有限公司 | 一种辛伐他汀侧链的酰基供体制备方法 |
CN103772247B (zh) * | 2014-01-06 | 2016-06-08 | 苏州汉酶生物技术有限公司 | 一种可用于合成辛伐他汀铵盐的酰基供体的制备方法 |
CN103725727B (zh) * | 2014-01-06 | 2016-06-08 | 苏州汉酶生物技术有限公司 | 一种辛伐他汀铵盐的制备方法 |
US20150315621A1 (en) * | 2014-04-30 | 2015-11-05 | The Regents Of The University Of California | One-pot fermentation process for simvastatin production |
KR101656235B1 (ko) * | 2014-10-07 | 2016-09-12 | 대한민국 | 신규 스코풀라리옵시스 브레비카울리스 m2479 균주 및 이의 용도 |
CN105586325A (zh) * | 2016-01-29 | 2016-05-18 | 重庆西南合成制药有限公司 | 一种洛伐他汀酰基转移酶突变体 |
CN108118042B (zh) * | 2016-11-30 | 2021-01-15 | 中国科学院青岛生物能源与过程研究所 | 2-甲基丁酸侧链水解酶和产莫纳可林j的曲霉菌株及其构建方法与应用 |
US11749375B2 (en) | 2017-09-14 | 2023-09-05 | Lifemine Therapeutics, Inc. | Human therapeutic targets and modulators thereof |
CN109402086B (zh) * | 2018-02-05 | 2020-08-11 | 中国科学院青岛生物能源与过程研究所 | 一种2-甲基丁酸侧链水解酶及其表达菌株和应用 |
JP7270301B2 (ja) | 2018-07-17 | 2023-05-10 | コナゲン インコーポレイテッド | ガンマラクトンの生合成生産 |
CN110857441B (zh) * | 2018-08-24 | 2022-07-29 | 中国科学院青岛生物能源与过程研究所 | 一种产莫纳可林j的曲霉菌及其构建方法与应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6391583B1 (en) | 1998-12-18 | 2002-05-21 | Wisconsin Alumni Research Foundation | Method of producing antihypercholesterolemic agents |
WO2002009697A1 (en) * | 2000-07-27 | 2002-02-07 | Plus Chemicals, B.V | Highly purified simvastatin compositions |
WO2003010324A2 (en) * | 2001-07-25 | 2003-02-06 | International Centre For Genetic Engineering And Biotechnology | Process for the preparation of simvastatin |
EP2032715B1 (en) | 2006-05-24 | 2012-02-01 | The Regents of the University of California | Methods and materials for making simvastatin and related compounds |
US20090197311A1 (en) * | 2006-06-20 | 2009-08-06 | Marco Alexander Van Den Berg | Method for the production of simvastatin |
WO2009077523A2 (en) | 2007-12-18 | 2009-06-25 | Dsm Ip Assets B.V. | Improved statin production |
HUE046680T2 (hu) | 2009-09-30 | 2020-03-30 | Codexis Inc | Javított Lov-D aciltranszferáz mediált acilezés |
-
2007
- 2007-05-24 EP EP07777257A patent/EP2032715B1/en active Active
- 2007-05-24 MX MX2008014778A patent/MX2008014778A/es active IP Right Grant
- 2007-05-24 US US12/227,671 patent/US8211664B2/en active Active
- 2007-05-24 CA CA2652883A patent/CA2652883C/en active Active
- 2007-05-24 AT AT07777257T patent/ATE543910T1/de active
- 2007-05-24 CN CN200780027455.0A patent/CN101490271B/zh active Active
- 2007-05-24 KR KR1020087031322A patent/KR101455794B1/ko active IP Right Grant
- 2007-05-24 WO PCT/US2007/012362 patent/WO2007139871A2/en active Application Filing
- 2007-05-24 RU RU2008151159/10A patent/RU2447152C2/ru active
- 2007-05-24 BR BRPI0711889A patent/BRPI0711889B8/pt active IP Right Grant
-
2008
- 2008-11-17 IL IL195341A patent/IL195341A/en active IP Right Grant
-
2012
- 2012-07-02 US US13/540,188 patent/US8951754B2/en active Active
-
2015
- 2015-01-16 US US14/599,100 patent/US9970037B2/en active Active
-
2018
- 2018-05-04 US US15/971,738 patent/US10793884B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
MX2008014778A (es) | 2009-01-28 |
KR20090016488A (ko) | 2009-02-13 |
US20090191602A1 (en) | 2009-07-30 |
CA2652883C (en) | 2016-01-05 |
WO2007139871A3 (en) | 2008-12-24 |
EP2032715A2 (en) | 2009-03-11 |
KR101455794B1 (ko) | 2014-11-03 |
BRPI0711889B1 (pt) | 2019-12-24 |
CN101490271B (zh) | 2014-03-12 |
US8951754B2 (en) | 2015-02-10 |
US20180355391A1 (en) | 2018-12-13 |
EP2032715B1 (en) | 2012-02-01 |
ATE543910T1 (de) | 2012-02-15 |
US10793884B2 (en) | 2020-10-06 |
US20120315680A1 (en) | 2012-12-13 |
WO2007139871A2 (en) | 2007-12-06 |
US8211664B2 (en) | 2012-07-03 |
CN101490271A (zh) | 2009-07-22 |
IL195341A (en) | 2017-01-31 |
IL195341A0 (en) | 2011-08-01 |
BRPI0711889A2 (pt) | 2012-01-10 |
CA2652883A1 (en) | 2007-12-06 |
US20150203884A1 (en) | 2015-07-23 |
EP2032715A4 (en) | 2010-12-15 |
RU2008151159A (ru) | 2010-06-27 |
US9970037B2 (en) | 2018-05-15 |
RU2447152C2 (ru) | 2012-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0711889B8 (pt) | método para produção de sinvastatina, composição de matéria, método para fabricação de huvastatina, método para fabricação de sinvastatina, e método para fabricação de uma composição de matéria de sinvastatina ou huvastatina | |
WO2008112939A3 (en) | Composition and method for making oligo-benzamide compounds | |
DE602007012559D1 (de) | H die schleimhaut | |
CU23774A3 (es) | Inhibición de arni de expresión de alfa-enac | |
CL2008003038A1 (es) | Compuestos derivados de pirrolidin-dionas espiroheterociclicas; proceso para la preparacion de dichos compuestos; composicion pesticida; metodo para combatir y controlar pestes; y compuestos intermediarios. | |
WO2007093627A3 (de) | Biozide zusammensetzung | |
BRPI0915749A2 (pt) | métodos, composições e sistemas para produção biossintética de 1,4-butanodiol | |
BRPI0908926A2 (pt) | Compostos de policarbonato-poliorganosiloxano e/ou poliuretano-poliorganosiloxano | |
EA200970580A1 (ru) | Таннат разагилина | |
JO2778B1 (en) | Certain vehicles, installations and methods | |
BRPI0823506A8 (pt) | composições e métodos para a produção de isoprene | |
WO2008002674A3 (en) | Bicyclic compositions and methods for modulating a kinase cascade | |
EA201001639A1 (ru) | Композиции и способы их получения и применения | |
ATE427965T1 (de) | Antikírper gegen 25-hydroxyvitamin d | |
MY150596A (en) | Hsp90 inhibitors | |
BRPI1008021A2 (pt) | Método para fabricação de 2,6-dioxabiciclo-(3.3.0)-octano-4,8-diona | |
WO2008002676A3 (en) | Biaryl compositions and methods for modulating a kinase cascade | |
TR201902386T4 (tr) | Parçacıklı kalsiyum karbonat üretme metodu. | |
WO2009009041A3 (en) | Compositions and methods for modulating a kinase cascade | |
WO2009074875A8 (en) | Sound-absorbing, resistant panels and process for making same | |
UA99936C2 (en) | Biaryl substituted azabicyclic alkane derivatives | |
BRPI0913105A2 (pt) | composição de óleo de engrenagem, e, métodos para melhorar as propriedades de tração de uma composição de óleo de engrenagem e de um óleo de engrenagem | |
BRPI0817479A2 (pt) | composição de óleo de engrenagem, e, método para melhorar as propriedade de tração de uma composição de óleo de engrenagem | |
EA200971140A1 (ru) | Триарильные соединения и композиции, их содержащие | |
ATE509931T1 (de) | Azaadamantanester- und carbamatderivate sowie anwendungsverfahren dafür |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 24/12/2019, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/05/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |